Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Special Survey on Parkinson's Disease Patients Treated Long-term Use of Pramipexole

tiistai 10. kesäkuuta 2014 päivittänyt: Boehringer Ingelheim

Pramipexole Special Survey on Long-Term Use

The survey is conducted to collect safety and effectiveness information on the use of Pramipexole for long time of period in daily clinical settings in Japan.

Tutkimuksen yleiskatsaus

Tila

Valmis

Ehdot

Opintotyyppi

Havainnollistava

Ilmoittautuminen (Todellinen)

1645

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

  • Japani
      • Agano, Japani
        • Boehringer Ingelheim Investigational Site
      • Aizuwakamatsu, Japani
        • Boehringer Ingelheim Investigational Site
      • Akashi, Japani
        • Boehringer Ingelheim Investigational Site
      • Akita, Japani
        • Boehringer Ingelheim Investigational Site
      • Asahikawa, Japani
        • Boehringer Ingelheim Investigational Site
      • Asakura, Japani
        • Boehringer Ingelheim Investigational Site
      • Ayagawa, Japani
        • Boehringer Ingelheim Investigational Site
      • Azumino, Japani
        • Boehringer Ingelheim Investigational Site
      • Bando, Japani
        • Boehringer Ingelheim Investigational Site
      • Beppu, Japani
        • Boehringer Ingelheim Investigational Site
      • Bihoro, Japani
        • Boehringer Ingelheim Investigational Site
      • Chiba, Japani
        • Boehringer Ingelheim Investigational Site
      • Chikusei, Japani
        • Boehringer Ingelheim Investigational Site
      • Chuo, Japani
        • Boehringer Ingelheim Investigational Site
      • Date, Japani
        • Boehringer Ingelheim Investigational Site
      • Ebetsu, Japani
        • Boehringer Ingelheim Investigational Site
      • Ebina, Japani
        • Boehringer Ingelheim Investigational Site
      • Eiheiji, Japani
        • Boehringer Ingelheim Investigational Site
      • Fuchu, Japani
        • Boehringer Ingelheim Investigational Site
      • Fuji, Japani
        • Boehringer Ingelheim Investigational Site
      • Fujieda, Japani
        • Boehringer Ingelheim Investigational Site
      • Fujinomiya, Japani
        • Boehringer Ingelheim Investigational Site
      • Fujioka, Japani
        • Boehringer Ingelheim Investigational Site
      • Fujisawa, Japani
        • Boehringer Ingelheim Investigational Site
      • Fujiyoshida, Japani
        • Boehringer Ingelheim Investigational Site
      • Fukaya, Japani
        • Boehringer Ingelheim Investigational Site
      • Fukui, Japani
        • Boehringer Ingelheim Investigational Site
      • Fukuoka, Japani
        • Boehringer Ingelheim Investigational Site
      • Fukushima, Japani
        • Boehringer Ingelheim Investigational Site
      • Fukuyama, Japani
        • Boehringer Ingelheim Investigational Site
      • Geisei, Japani
        • Boehringer Ingelheim Investigational Site
      • Gifu, Japani
        • Boehringer Ingelheim Investigational Site
      • Ginowan, Japani
        • Boehringer Ingelheim Investigational Site
      • Hachinohe, Japani
        • Boehringer Ingelheim Investigational Site
      • Hadano, Japani
        • Boehringer Ingelheim Investigational Site
      • Haebaru, Japani
        • Boehringer Ingelheim Investigational Site
      • Hagahama, Japani
        • Boehringer Ingelheim Investigational Site
      • Hakodate, Japani
        • Boehringer Ingelheim Investigational Site
      • Hamada, Japani
        • Boehringer Ingelheim Investigational Site
      • Hamamatsu, Japani
        • Boehringer Ingelheim Investigational Site
      • Hayashima, Japani
        • Boehringer Ingelheim Investigational Site
      • Higashimurayama, Japani
        • Boehringer Ingelheim Investigational Site
      • Higashiosaka, Japani
        • Boehringer Ingelheim Investigational Site
      • Higashiyamato, Japani
        • Boehringer Ingelheim Investigational Site
      • Himeji, Japani
        • Boehringer Ingelheim Investigational Site
      • Hiratsuka, Japani
        • Boehringer Ingelheim Investigational Site
      • Hirokawa, Japani
        • Boehringer Ingelheim Investigational Site
      • Hirosaki, Japani
        • Boehringer Ingelheim Investigational Site
      • Hiroshima, Japani
        • Boehringer Ingelheim Investigational Site
      • Hita, Japani
        • Boehringer Ingelheim Investigational Site
      • Hofu, Japani
        • Boehringer Ingelheim Investigational Site
      • Ibaragi, Japani
        • Boehringer Ingelheim Investigational Site
      • Ichikikushikino, Japani
        • Boehringer Ingelheim Investigational Site
      • Ichinomiya, Japani
        • Boehringer Ingelheim Investigational Site
      • Ichinoseki, Japani
        • Boehringer Ingelheim Investigational Site
      • Iizuka, Japani
        • Boehringer Ingelheim Investigational Site
      • Ikeda, Japani
        • Boehringer Ingelheim Investigational Site
      • Ikoma, Japani
        • Boehringer Ingelheim Investigational Site
      • Ina, Japani
        • Boehringer Ingelheim Investigational Site
      • Inazawa, Japani
        • Boehringer Ingelheim Investigational Site
      • Inba, Japani
        • Boehringer Ingelheim Investigational Site
      • Inuyama, Japani
        • Boehringer Ingelheim Investigational Site
      • Isezaki, Japani
        • Boehringer Ingelheim Investigational Site
      • Itoigawa, Japani
        • Boehringer Ingelheim Investigational Site
      • Iwaki, Japani
        • Boehringer Ingelheim Investigational Site
      • Iwata, Japani
        • Boehringer Ingelheim Investigational Site
      • Joetsu, Japani
        • Boehringer Ingelheim Investigational Site
      • Kagoshima, Japani
        • Boehringer Ingelheim Investigational Site
      • Kahoku, Japani
        • Boehringer Ingelheim Investigational Site
      • Kajiki, Japani
        • Boehringer Ingelheim Investigational Site
      • Kakegawa, Japani
        • Boehringer Ingelheim Investigational Site
      • Kakogawa, Japani
        • Boehringer Ingelheim Investigational Site
      • Kamisu, Japani
        • Boehringer Ingelheim Investigational Site
      • Kamogawa, Japani
        • Boehringer Ingelheim Investigational Site
      • Kanazawa, Japani
        • Boehringer Ingelheim Investigational Site
      • Kannonji, Japani
        • Boehringer Ingelheim Investigational Site
      • Karatsu, Japani
        • Boehringer Ingelheim Investigational Site
      • Kashima, Japani
        • Boehringer Ingelheim Investigational Site
      • Kashiwa, Japani
        • Boehringer Ingelheim Investigational Site
      • Kashiwazaki, Japani
        • Boehringer Ingelheim Investigational Site
      • Kasukabe, Japani
        • Boehringer Ingelheim Investigational Site
      • Kato, Japani
        • Boehringer Ingelheim Investigational Site
      • Kawagoe, Japani
        • Boehringer Ingelheim Investigational Site
      • Kawasaki, Japani
        • Boehringer Ingelheim Investigational Site
      • Kawatana, Japani
        • Boehringer Ingelheim Investigational Site
      • Kikugawa, Japani
        • Boehringer Ingelheim Investigational Site
      • Kirishima, Japani
        • Boehringer Ingelheim Investigational Site
      • Kitakyushu, Japani
        • Boehringer Ingelheim Investigational Site
      • Kiyose, Japani
        • Boehringer Ingelheim Investigational Site
      • Kiyotake, Japani
        • Boehringer Ingelheim Investigational Site
      • Kizugawa, Japani
        • Boehringer Ingelheim Investigational Site
      • Kobayashi, Japani
        • Boehringer Ingelheim Investigational Site
      • Kobe, Japani
        • Boehringer Ingelheim Investigational Site
      • Kochi, Japani
        • Boehringer Ingelheim Investigational Site
      • Kodaira, Japani
        • Boehringer Ingelheim Investigational Site
      • Kofu, Japani
        • Boehringer Ingelheim Investigational Site
      • Koga, Japani
        • Boehringer Ingelheim Investigational Site
      • Kokubunji, Japani
        • Boehringer Ingelheim Investigational Site
      • Komae, Japani
        • Boehringer Ingelheim Investigational Site
      • Komatsu, Japani
        • Boehringer Ingelheim Investigational Site
      • Komoro, Japani
        • Boehringer Ingelheim Investigational Site
      • Koriyama, Japani
        • Boehringer Ingelheim Investigational Site
      • Koshi, Japani
        • Boehringer Ingelheim Investigational Site
      • Koshigawa, Japani
        • Boehringer Ingelheim Investigational Site
      • Kumamoto, Japani
        • Boehringer Ingelheim Investigational Site
      • Kurashiki, Japani
        • Boehringer Ingelheim Investigational Site
      • Kurayoshi, Japani
        • Boehringer Ingelheim Investigational Site
      • Kure, Japani
        • Boehringer Ingelheim Investigational Site
      • Kurume, Japani
        • Boehringer Ingelheim Investigational Site
      • Kushiro, Japani
        • Boehringer Ingelheim Investigational Site
      • Kutchan, Japani
        • Boehringer Ingelheim Investigational Site
      • Kuwana, Japani
        • Boehringer Ingelheim Investigational Site
      • Kyonan, Japani
        • Boehringer Ingelheim Investigational Site
      • Kyoto, Japani
        • Boehringer Ingelheim Investigational Site
      • Maebaru, Japani
        • Boehringer Ingelheim Investigational Site
      • Maebashi, Japani
        • Boehringer Ingelheim Investigational Site
      • Maibara, Japani
        • Boehringer Ingelheim Investigational Site
      • Maizuru, Japani
        • Boehringer Ingelheim Investigational Site
      • Marugame, Japani
        • Boehringer Ingelheim Investigational Site
      • Matsuda, Japani
        • Boehringer Ingelheim Investigational Site
      • Matsudo, Japani
        • Boehringer Ingelheim Investigational Site
      • Matsue, Japani
        • Boehringer Ingelheim Investigational Site
      • Matsumoto, Japani
        • Boehringer Ingelheim Investigational Site
      • Matsuyama, Japani
        • Boehringer Ingelheim Investigational Site
      • Mibu, Japani
        • Boehringer Ingelheim Investigational Site
      • Mihara, Japani
        • Boehringer Ingelheim Investigational Site
      • Miki, Japani
        • Boehringer Ingelheim Investigational Site
      • Minakami, Japani
        • Boehringer Ingelheim Investigational Site
      • Minamata, Japani
        • Boehringer Ingelheim Investigational Site
      • Minobu, Japani
        • Boehringer Ingelheim Investigational Site
      • Misashino, Japani
        • Boehringer Ingelheim Investigational Site
      • Mito, Japani
        • Boehringer Ingelheim Investigational Site
      • Miyaki, Japani
        • Boehringer Ingelheim Investigational Site
      • Miyakonojo, Japani
        • Boehringer Ingelheim Investigational Site
      • Miyazaki, Japani
        • Boehringer Ingelheim Investigational Site
      • Mooka, Japani
        • Boehringer Ingelheim Investigational Site
      • Moriguchi, Japani
        • Boehringer Ingelheim Investigational Site
      • Morioka, Japani
        • Boehringer Ingelheim Investigational Site
      • Moriya, Japani
        • Boehringer Ingelheim Investigational Site
      • Moriyama, Japani
        • Boehringer Ingelheim Investigational Site
      • Muroran, Japani
        • Boehringer Ingelheim Investigational Site
      • Nagakute, Japani
        • Boehringer Ingelheim Investigational Site
      • Nagaoka, Japani
        • Boehringer Ingelheim Investigational Site
      • Nagaokakyo, Japani
        • Boehringer Ingelheim Investigational Site
      • Nagasaki, Japani
        • Boehringer Ingelheim Investigational Site
      • Nagoya, Japani
        • Boehringer Ingelheim Investigational Site
      • Nangoku, Japani
        • Boehringer Ingelheim Investigational Site
      • Nara, Japani
        • Boehringer Ingelheim Investigational Site
      • Narita, Japani
        • Boehringer Ingelheim Investigational Site
      • Naruto, Japani
        • Boehringer Ingelheim Investigational Site
      • Nichinan, Japani
        • Boehringer Ingelheim Investigational Site
      • Niigata, Japani
        • Boehringer Ingelheim Investigational Site
      • Niihama, Japani
        • Boehringer Ingelheim Investigational Site
      • Nikko, Japani
        • Boehringer Ingelheim Investigational Site
      • Nishigo, Japani
        • Boehringer Ingelheim Investigational Site
      • Nishihara, Japani
        • Boehringer Ingelheim Investigational Site
      • Nishinomiya, Japani
        • Boehringer Ingelheim Investigational Site
      • Nishio, Japani
        • Boehringer Ingelheim Investigational Site
      • Nishitokyo, Japani
        • Boehringer Ingelheim Investigational Site
      • Nobeoka, Japani
        • Boehringer Ingelheim Investigational Site
      • Noboribetsu, Japani
        • Boehringer Ingelheim Investigational Site
      • Numazu, Japani
        • Boehringer Ingelheim Investigational Site
      • Obama, Japani
        • Boehringer Ingelheim Investigational Site
      • Obihiro, Japani
        • Boehringer Ingelheim Investigational Site
      • Odate, Japani
        • Boehringer Ingelheim Investigational Site
      • Odawara, Japani
        • Boehringer Ingelheim Investigational Site
      • Ofunato, Japani
        • Boehringer Ingelheim Investigational Site
      • Ogaki, Japani
        • Boehringer Ingelheim Investigational Site
      • Ohzu, Japani
        • Boehringer Ingelheim Investigational Site
      • Oiso, Japani
        • Boehringer Ingelheim Investigational Site
      • Oita, Japani
        • Boehringer Ingelheim Investigational Site
      • Ojiya, Japani
        • Boehringer Ingelheim Investigational Site
      • Okawa, Japani
        • Boehringer Ingelheim Investigational Site
      • Okayama, Japani
        • Boehringer Ingelheim Investigational Site
      • Omaezaki, Japani
        • Boehringer Ingelheim Investigational Site
      • Omura, Japani
        • Boehringer Ingelheim Investigational Site
      • Omuta, Japani
        • Boehringer Ingelheim Investigational Site
      • Onga, Japani
        • Boehringer Ingelheim Investigational Site
      • Onojo, Japani
        • Boehringer Ingelheim Investigational Site
      • Onomichi, Japani
        • Boehringer Ingelheim Investigational Site
      • Osaka, Japani
        • Boehringer Ingelheim Investigational Site
      • Otsu, Japani
        • Boehringer Ingelheim Investigational Site
      • Ozu, Japani
        • Boehringer Ingelheim Investigational Site
      • Sado, Japani
        • Boehringer Ingelheim Investigational Site
      • Saga, Japani
        • Boehringer Ingelheim Investigational Site
      • Sagamihara, Japani
        • Boehringer Ingelheim Investigational Site
      • Saitama, Japani
        • Boehringer Ingelheim Investigational Site
      • Sakai, Japani
        • Boehringer Ingelheim Investigational Site
      • Sakaide, Japani
        • Boehringer Ingelheim Investigational Site
      • Sakata, Japani
        • Boehringer Ingelheim Investigational Site
      • Saku, Japani
        • Boehringer Ingelheim Investigational Site
      • Sanjo, Japani
        • Boehringer Ingelheim Investigational Site
      • Sano, Japani
        • Boehringer Ingelheim Investigational Site
      • Sanyoonoda, Japani
        • Boehringer Ingelheim Investigational Site
      • Sapporo, Japani
        • Boehringer Ingelheim Investigational Site
      • Sasebo, Japani
        • Boehringer Ingelheim Investigational Site
      • Seijo, Japani
        • Boehringer Ingelheim Investigational Site
      • Sendai, Japani
        • Boehringer Ingelheim Investigational Site
      • Shimabara, Japani
        • Boehringer Ingelheim Investigational Site
      • Shimonoseki, Japani
        • Boehringer Ingelheim Investigational Site
      • Shimotsuke, Japani
        • Boehringer Ingelheim Investigational Site
      • Shingu, Japani
        • Boehringer Ingelheim Investigational Site
      • Shinshiro, Japani
        • Boehringer Ingelheim Investigational Site
      • Shizuoka, Japani
        • Boehringer Ingelheim Investigational Site
      • Shunan, Japani
        • Boehringer Ingelheim Investigational Site
      • Soo, Japani
        • Boehringer Ingelheim Investigational Site
      • Suita, Japani
        • Boehringer Ingelheim Investigational Site
      • Tajimi, Japani
        • Boehringer Ingelheim Investigational Site
      • Takamatsu, Japani
        • Boehringer Ingelheim Investigational Site
      • Takanabe, Japani
        • Boehringer Ingelheim Investigational Site
      • Takaoka, Japani
        • Boehringer Ingelheim Investigational Site
      • Takasago, Japani
        • Boehringer Ingelheim Investigational Site
      • Takasaki, Japani
        • Boehringer Ingelheim Investigational Site
      • Takatsuki, Japani
        • Boehringer Ingelheim Investigational Site
      • Takehara, Japani
        • Boehringer Ingelheim Investigational Site
      • Toda, Japani
        • Boehringer Ingelheim Investigational Site
      • Togitsu, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokoname, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokushima, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokyo Adachi-ku, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokyo Bunkyo-ku, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokyo Chiyoda-ku, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokyo Edogawa-ku, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokyo Itabashi-ku, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokyo Katsushika-ku, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokyo Kita-ku, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokyo Meguro-ku, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokyo Minayo-ku, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokyo Nakano-ku, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokyo Nerima-ku, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokyo Ota-ku, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokyo Setagaya-ku, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokyo Shinagawa-ku, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokyo Shinjuku-ku, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokyo Suginami-ku, Japani
        • Boehringer Ingelheim Investigational Site
      • Tokyo Toshima-ku, Japani
        • Boehringer Ingelheim Investigational Site
      • Tomakomai, Japani
        • Boehringer Ingelheim Investigational Site
      • Tomiai, Japani
        • Boehringer Ingelheim Investigational Site
      • Tondabayashi, Japani
        • Boehringer Ingelheim Investigational Site
      • Toon, Japani
        • Boehringer Ingelheim Investigational Site
      • Toride, Japani
        • Boehringer Ingelheim Investigational Site
      • Toyama, Japani
        • Boehringer Ingelheim Investigational Site
      • Toyoake, Japani
        • Boehringer Ingelheim Investigational Site
      • Toyokawa, Japani
        • Boehringer Ingelheim Investigational Site
      • Toyonaka, Japani
        • Boehringer Ingelheim Investigational Site
      • Toyooka, Japani
        • Boehringer Ingelheim Investigational Site
      • Tsu, Japani
        • Boehringer Ingelheim Investigational Site
      • Tsubata, Japani
        • Boehringer Ingelheim Investigational Site
      • Tsuchiura, Japani
        • Boehringer Ingelheim Investigational Site
      • Tsukuba, Japani
        • Boehringer Ingelheim Investigational Site
      • Tsuruoka, Japani
        • Boehringer Ingelheim Investigational Site
      • Uchinada, Japani
        • Boehringer Ingelheim Investigational Site
      • Ueda, Japani
        • Boehringer Ingelheim Investigational Site
      • Uji, Japani
        • Boehringer Ingelheim Investigational Site
      • Ujo, Japani
        • Boehringer Ingelheim Investigational Site
      • Urayasu, Japani
        • Boehringer Ingelheim Investigational Site
      • Uruma, Japani
        • Boehringer Ingelheim Investigational Site
      • Utsunomiya, Japani
        • Boehringer Ingelheim Investigational Site
      • Wakayama, Japani
        • Boehringer Ingelheim Investigational Site
      • Yamagata, Japani
        • Boehringer Ingelheim Investigational Site
      • Yamaguchi, Japani
        • Boehringer Ingelheim Investigational Site
      • Yamamoto, Japani
        • Boehringer Ingelheim Investigational Site
      • Yanai, Japani
        • Boehringer Ingelheim Investigational Site
      • Yao, Japani
        • Boehringer Ingelheim Investigational Site
      • Yashiro, Japani
        • Boehringer Ingelheim Investigational Site
      • Yazu, Japani
        • Boehringer Ingelheim Investigational Site
      • Yokkaichi, Japani
        • Boehringer Ingelheim Investigational Site
      • Yokohama, Japani
        • Boehringer Ingelheim Investigational Site
      • Yokote, Japani
        • Boehringer Ingelheim Investigational Site
      • Yoro, Japani
        • Boehringer Ingelheim Investigational Site
      • Yoshinogawa, Japani
        • Boehringer Ingelheim Investigational Site
      • Yufu, Japani
        • Boehringer Ingelheim Investigational Site
      • Zama, Japani
        • Boehringer Ingelheim Investigational Site

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

  • Lapsi
  • Aikuinen
  • Vanhempi Aikuinen

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Kaikki

Näytteenottomenetelmä

Ei-todennäköisyysnäyte

Tutkimusväestö

Parkinson's disease patients in daily clinical settings

Kuvaus

Inclusion Criteria:

Patients with Parkinson's disease

Exclusion Criteria:

Patients should have been treated according to the Japanese insert slip

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Proportion of Adverse Events, Adverse Drug Reactions, Serious Adverse Events
Aikaikkuna: during 18 months
The aim of this Post Marketing Surveillance (PMS) was to obtain long-term safety data with treatment of pramipexole in Parkinson's disease (PD) patients. Therefore these items were considered as a safety evaluation.
during 18 months

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Clinical Global Impression of Improvement
Aikaikkuna: 18 months
Investigators evaluation of the PD symptoms on a rating scale of 5 categories (very much improved, much improved, minimally improved, no effect, and unassessable).
18 months
Change From Baseline in Unified Parkinson's Disease Rating Scale (UPDRS) Part III Total Score
Aikaikkuna: Baseline and at 18 months (or at the time of discontinuation)
Motor examination is assessed by 27 questionnaire items in UPDRS Part III section. Each item is scored from 0 (best) to 4 (worst), and the total score of UPDRS Part III is from 0 (best) to 108 (worst). A decrease in the score means improvement.
Baseline and at 18 months (or at the time of discontinuation)
Change From Baseline in Modified Hoehn & Yahr Rating Scale
Aikaikkuna: Baseline and at 18 months (or at the time of discontinuation)
A severity of PD symptom are assessed by Modified Hoehn & Yahr rating scale. This scale consist of 10 levels including additional evaluation levels defined in Japan. Ten levels are described by 0 (best), 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5 (worst).
Baseline and at 18 months (or at the time of discontinuation)

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Sponsori

Boehringer Ingelheim

Julkaisuja ja hyödyllisiä linkkejä

Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.

Hyödyllisiä linkkejä

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus

Sunnuntai 1. helmikuuta 2004

Ensisijainen valmistuminen (Todellinen)

Sunnuntai 1. maaliskuuta 2009

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Torstai 31. tammikuuta 2008

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Keskiviikko 13. helmikuuta 2008

Ensimmäinen Lähetetty (Arvio)

Torstai 14. helmikuuta 2008

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Arvio)

Perjantai 11. heinäkuuta 2014

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Tiistai 10. kesäkuuta 2014

Viimeksi vahvistettu

Sunnuntai 1. kesäkuuta 2014

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Muita asiaankuuluvia MeSH-ehtoja

Muut tutkimustunnusnumerot

  • 248.547

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa